Literature DB >> 1978306

Transdermal delivery of narcotic analgesics: pH, anatomical, and subject influences on cutaneous permeability of fentanyl and sufentanil.

S D Roy1, G L Flynn.   

Abstract

The permeation of fentanyl and sufentanil through cadaver skin membranes was investigated using in vitro diffusion cell techniques. Neither drug influenced the permeation of the other when they were concurrently applied to the skin membrane. With respect to transdermal delivery, short diffusion lag times of less than 0.5 hr were observed for each compound. Their permeation rates through heat-isolated epidermis and dermatomed (200- to 250-microns) skin sections were essentially the same. However, when the stratum corneum was removed by tape stripping, the respective permeability coefficients were increased greater than 30-fold, establishing the stratum corneum as the principal barrier to their skin permeation. Permeation was also studied as a function of pH. From pH 4 to pH 8 the permeability coefficients of both fentanyl and sufentanil, calculated from the total solution concentration regardless of ionization, increased exponentially. The free base is thus responsible for the relatively facile skin permeation of these drugs. Factoring of the independent permeability coefficients of the ionized and free-base forms was possible, with the latter being over two log orders larger than seen for the protonated species. Permeability coefficients of fentanyl and sufentanil through skin sections obtained from different cadavers varied four- to fivefold. Neither gender nor age was a flux-determining variable for either drug. The permeability coefficients of the drugs through skin sites as diverse as the sole of the foot, chest, thigh, and abdomen were remarkably similar. Their fluxes were sufficient for transdermal administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978306     DOI: 10.1023/a:1015912932416

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Solubility and related physicochemical properties of narcotic analgesics.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1988-09       Impact factor: 4.200

2.  Permeation of water contaminative phenols through hairless mouse skin.

Authors:  A S Huq; N F Ho; N Husari; G L Flynn; W E Jetzer; L Condie
Journal:  Arch Environ Contam Toxicol       Date:  1986-09       Impact factor: 2.804

Review 3.  Pharmacokinetics of drugs administered intravenously.

Authors:  C C Hug
Journal:  Anesth Analg       Date:  1978 Nov-Dec       Impact factor: 5.108

4.  Improving analgesic therapy.

Authors:  C C Hug
Journal:  Anesthesiology       Date:  1980-12       Impact factor: 7.892

5.  Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil.

Authors:  S D Roy; G L Flynn
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

6.  In vivo percutaneous penetration of some organic compounds related to anatomic site in humans: predictive assessment by the stripping method.

Authors:  A Rougier; C Lotte; H I Maibach
Journal:  J Pharm Sci       Date:  1987-06       Impact factor: 3.534

7.  Pharmacokinetics of fentanyl as determined by radioimmunoassay.

Authors:  R Schleimer; E Benjamini; J Eisele; G Henderson
Journal:  Clin Pharmacol Ther       Date:  1978-02       Impact factor: 6.875

8.  Absorption characteristics of transdermally administered fentanyl.

Authors:  J R Varvel; S L Shafer; S S Hwang; P A Coen; D R Stanski
Journal:  Anesthesiology       Date:  1989-06       Impact factor: 7.892

9.  Drug permeation through human skin II: Permeability of ionizable compounds.

Authors:  J Swarbrick; G Lee; J Brom; N P Gensmantel
Journal:  J Pharm Sci       Date:  1984-10       Impact factor: 3.534

10.  Excretion and biotransformation of alfentanil and sufentanil in rats and dogs.

Authors:  W Meuldermans; J Hendrickx; W Lauwers; R Hurkmans; E Swysen; J Thijssen; P Timmerman; R Woestenborghs; J Heykants
Journal:  Drug Metab Dispos       Date:  1987 Nov-Dec       Impact factor: 3.922

View more
  24 in total

1.  ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products.

Authors: 
Journal:  J Med Toxicol       Date:  2016-06

2.  Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line.

Authors:  Yoshiyuki Hoya; Tomoyoshi Okamoto; Katsuhiko Yanaga
Journal:  Support Care Cancer       Date:  2010-03-31       Impact factor: 3.603

3.  Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport.

Authors:  R Vanbever; N D Morre; V Préat
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

Review 4.  Transdermal fentanyl. A review of its pharmacological properties and therapeutic efficacy in pain control.

Authors:  W Jeal; P Benfield
Journal:  Drugs       Date:  1997-01       Impact factor: 9.546

Review 5.  Transdermal patches: history, development and pharmacology.

Authors:  Michael N Pastore; Yogeshvar N Kalia; Michael Horstmann; Michael S Roberts
Journal:  Br J Pharmacol       Date:  2015-03-18       Impact factor: 8.739

Review 6.  Opioid Management in Older Adults with Chronic Kidney Disease: A Review.

Authors:  Montgomery T Owsiany; Chelsea E Hawley; Laura K Triantafylidis; Julie M Paik
Journal:  Am J Med       Date:  2019-07-08       Impact factor: 4.965

Review 7.  The Role of Opioid Analgesics in Geriatric Pain Management.

Authors:  Jennifer Greene Naples; Walid F Gellad; Joseph T Hanlon
Journal:  Clin Geriatr Med       Date:  2016-08-09       Impact factor: 3.076

8.  ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders.

Authors:  Michael J Moss; Brandon J Warrick; Lewis S Nelson; Charles A McKay; Pierre-André Dubé; Sophie Gosselin; Robert B Palmer; Andrew I Stolbach
Journal:  J Med Toxicol       Date:  2017-08-25

9.  An in vitro study of diamorphine permeation through premature human neonatal skin.

Authors:  D A Barrett; N Rutter; S S Davis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

10.  Evaluation of skin permeation of β-blockers for topical drug delivery.

Authors:  Doungdaw Chantasart; Jinsong Hao; S Kevin Li
Journal:  Pharm Res       Date:  2012-12-04       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.